标题
Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
作者
关键词
-
出版物
Molecular Diagnosis & Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-04-30
DOI
10.1007/s40291-019-00400-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Selection of PD1/PD-L1 X-Aptamers
- (2018) Hongyu Wang et al. BIOCHIMIE
- Systematic evaluation of cell-SELEX enriched aptamers binding to breast cancer cells
- (2018) Laia Civit et al. BIOCHIMIE
- RNA Aptamers Recognizing Murine CCL17 Inhibit T Cell Chemotaxis and Reduce Contact Hypersensitivity In Vivo
- (2018) Lorenz Fülle et al. MOLECULAR THERAPY
- Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes
- (2018) Valeriy Domenyuk et al. Nature Communications
- Aptamers: novelty tools for cancer biology
- (2018) Ricardo L. Pereira et al. Oncotarget
- Aptamer-miR-34c conjugate affects cell proliferation of non-small cell lung cancer cells
- (2018) Valentina Russo et al. Molecular Therapy-Nucleic Acids
- Therapeutic Oligonucleotides: State of the Art
- (2018) C.I. Edvard Smith et al. Annual Review of Pharmacology and Toxicology
- Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer
- (2018) Romualdo Troisi et al. NUCLEIC ACIDS RESEARCH
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
- (2017) Bo-Tsang Huang et al. Molecular Therapy-Nucleic Acids
- An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications
- (2017) Evan N. Dunn et al. Ophthalmic Surgery Lasers & Imaging Retina
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
- (2016) Carla L. Esposito et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Fit for the Eye: Aptamers in Ocular Disorders
- (2016) Daniel W. Drolet et al. Nucleic Acid Therapeutics
- 2′Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors
- (2016) Youngju Lee et al. Nucleic Acid Therapeutics
- Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
- (2016) Margherita Iaboni et al. Molecular Therapy-Nucleic Acids
- A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects
- (2016) Wei-Yun Lai et al. Molecular Therapy-Nucleic Acids
- From selection hits to clinical leads: progress in aptamer discovery
- (2016) Keith E Maier et al. Molecular Therapy-Methods & Clinical Development
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- Edelman's view on the discovery of antibodies
- (2015) Domenico Ribatti IMMUNOLOGY LETTERS
- Reproducibility crisis: Blame it on the antibodies
- (2015) Monya Baker NATURE
- Reproducibility: Standardize antibodies used in research
- (2015) Andrew Bradbury et al. NATURE
- Transcription yield of fully 2′-modified RNA can be increased by the addition of thermostabilizing mutations to T7 RNA polymerase mutants
- (2015) Adam J. Meyer et al. NUCLEIC ACIDS RESEARCH
- Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice
- (2015) Katherine Perschbacher et al. Nucleic Acid Therapeutics
- Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
- (2015) Aaron Prodeus et al. Molecular Therapy-Nucleic Acids
- Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein
- (2015) Chang Ho Lee et al. Molecular Therapy-Nucleic Acids
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
- (2014) Carla L Esposito et al. MOLECULAR THERAPY
- Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
- (2014) Jiehua Zhou et al. Molecular Therapy-Nucleic Acids
- The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
- (2013) F. Schwoebel et al. BLOOD
- The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
- (2013) J. Hoellenriegel et al. BLOOD
- Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
- (2013) E. Gilboa et al. CLINICAL CANCER RESEARCH
- Potential Capacity of Aptamers to Trigger Immune Activation in Human Blood
- (2013) Meltem Avci-Adali et al. PLoS One
- Aflibercept in wet AMD: specific role and optimal use
- (2013) Francesco Semeraro et al. Drug Design Development and Therapy
- A Universal Protein Tag for Delivery of SiRNA-Aptamer Chimeras
- (2013) Hong Yan Liu et al. Scientific Reports
- Monoclonal antibody therapeutics: history and future
- (2012) Nicholas APS Buss et al. CURRENT OPINION IN PHARMACOLOGY
- A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity
- (2012) K. M. BOMPIANI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Targeting Axl With an High-affinity Inhibitory Aptamer
- (2012) Laura Cerchia et al. MOLECULAR THERAPY
- Structural Requirements for the Procoagulant Activity of Nucleic Acids
- (2012) Julia Gansler et al. PLoS One
- Synthetic Genetic Polymers Capable of Heredity and Evolution
- (2012) V. B. Pinheiro et al. SCIENCE
- Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
- (2011) E. K. Waters et al. BLOOD
- Enzymatic Recognition of 2′-Modified Ribonucleoside 5′-Triphosphates: Towards the Evolution of Versatile Aptamers
- (2011) Lasse H. Lauridsen et al. CHEMBIOCHEM
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention
- (2010) Mauricio G. Cohen et al. CIRCULATION
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamers as a model for functional evaluation of LNA and 2′-amino LNA
- (2009) Frank J. Hernandez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Polymerase engineering: towards the encoded synthesis of unnatural biopolymers
- (2009) David Loakes et al. CHEMICAL COMMUNICATIONS
- Aptamers Influence the Hemostatic System by Activating the Intrinsic Coagulation Pathway in an In Vitro Chandler-Loop Model
- (2009) Angela Paul et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779
- (2009) J. L. DIENER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- In vivo selection of tumor-targeting RNA motifs
- (2009) Jing Mi et al. Nature Chemical Biology
- Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
- (2008) Volha Ninichuk et al. AMERICAN JOURNAL OF PATHOLOGY
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
- (2008) James O. McNamara et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now